Quarterly predictions, page-36

There are of course a number of variables and I like the conservative approach. For instance, zinc prices may head higher during the year, treatment charges may retreat and production levels may be higher. In addition recovery rates may also be higher. All those would positively impact on revenue. Unfortunately assumptions may be somewhat different to what eventuates. One thing we know for pretty sure is that ramping continues.

As ramping continues C1 costs will reduce - which again will be a positive. If the stars align us shareholders should see higher share price - currently we are in the doldrums.

In the event that zinc prices climb to above US$1.30/lb sustainably and plant humming along nicely then I expect this to fly.